Search research articles
Contact Us
Filters
Showing results (321-330 of 418) with videos related to
Page
of 42
Sort By:
The New England Journal of Medicine
|
June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanoma
Keith T Flaherty, Caroline Robert, Peter Hersey, et al.
Scientific Reports
|
March 10, 2017
Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors
Yunching Chen, Ya-Chi Liu, Yun-Chieh Sung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2024
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J
Roisin M Connolly, Victoria Wang, David M Hyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2020
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
Young K Chae, Fangxin Hong, Christos Vaklavas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK Inhibitors
Andrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Annals of Surgical Oncology
|
February 18, 2014
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients
Charles M Balch, John F Thompson, Jeffrey E Gershenwald, et al.
JCO Precision Oncology
|
August 27, 2025
PIK3CB Inhibitor GSK2636771 in Cancers With <i>PTEN</i> Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P
Filip Janku, Opeyemi A Jegede, Shannon L Puhalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2015
Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors
Ravi K Amaravadi, Kathryn E Hamilton, Xiaohong Ma, et al.
Cancer Discovery
|
June 6, 2020
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Gretchen M Alicea, Vito W Rebecca, Aaron R Goldman, et al.
Lancet (London, England)
|
March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B Haas, Judith Manola, Robert G Uzzo, et al.
Page
of 42
Search research articles
Search
Showing results (321-330 of 418) with videos related to
Sort By:
Page
of 42
The New England Journal of Medicine
|
June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanoma
Keith T Flaherty, Caroline Robert, Peter Hersey, et al.
Scientific Reports
|
March 10, 2017
Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors
Yunching Chen, Ya-Chi Liu, Yun-Chieh Sung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2024
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J
Roisin M Connolly, Victoria Wang, David M Hyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2020
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
Young K Chae, Fangxin Hong, Christos Vaklavas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK Inhibitors
Andrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Annals of Surgical Oncology
|
February 18, 2014
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients
Charles M Balch, John F Thompson, Jeffrey E Gershenwald, et al.
JCO Precision Oncology
|
August 27, 2025
PIK3CB Inhibitor GSK2636771 in Cancers With <i>PTEN</i> Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P
Filip Janku, Opeyemi A Jegede, Shannon L Puhalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2015
Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors
Ravi K Amaravadi, Kathryn E Hamilton, Xiaohong Ma, et al.
Cancer Discovery
|
June 6, 2020
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Gretchen M Alicea, Vito W Rebecca, Aaron R Goldman, et al.
Lancet (London, England)
|
March 13, 2016
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B Haas, Judith Manola, Robert G Uzzo, et al.
Page
of 42